Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression

Lupus

Volumn 17, Issue 7, 2008, Pages 654-662

  Jin, Ou ^a   Kavikondala, Sushma ^a   Sun, Lingyun ^b   Fu, Rong ^a   Mok, Mo Yin ^a   Chan, Albert ^a   Yeung, Joseph ^a   Lau, Chak Sing ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NANJING UNIVERSITY   (China)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Antigen presenting cells; Autoimmunity; Cell surface markers

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; BLOOD DENDRITIC CELL ANTIGEN 1; BLOOD DENDRITIC CELL ANTIGEN 4; CD83 ANTIGEN; CD86 ANTIGEN; CELL ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR CCR7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CELL ISOLATION; CIRCULATING PLASMACYTOID DENDRITIC CELL; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ACTIVITY; FEMALE; HUMAN; INFECTION SENSITIVITY; MALE; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL SEPARATION; CELL SHAPE; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOMAGNETIC SEPARATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYELOID CELLS;

EID: 48249107477     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308089410     Document Type: Article

References (54)

1. Tan, EM, Kunkel, HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966; 96: 464-471.
2. Gaipl, US, Voll, RE, Sheriff, A, Franz, S, Kalden, JR, Herrmann, M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 2005; 4: 189-194.
3. Jin, O, Sun, LY, Zhou, KX, et al. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus. Clin Rheumato 2005; 24: 107-110.
4. Perniok, A, Wedekind, F, Herrmann, M, Specker, C, Schneider, M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998; 7: 113-118.
5. Emlen, W, Niebur, J, Kadera, R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685-3692.
6. Herrmann, M. Vol,1 RE, Zoller, OM, Hagenhofer, M, Ponner, BB, Kalden, JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1241-1250.
7. Ren, Y, Tang, J, Mok, MY, Chan, AW, Wu, A, Lau, CS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2888-2897.
8. Matassov, D, Kagan, T, Leblanc, J, Sikorska, M, Zakeri, Z. Measurement of apoptosis by DNA fragmentation. Methods Mol Biol 2004; 282: 1-17.
9. Sano, H, Takai, O, Harata, N, Yoshinaga, K, Kodama-Kamada, I, Sasaki, T. Binding properties of human anti-DNA antibodies to cloned human DNA fragments. Scand J Immunol 1989; 30: 51-63.
10. Sato, Y, Miyata, M, Nishimaki, T, Kochi, H, Kasukawa, R. CpG motif-containing DNA fragments from sera of patients with systemic lupus erythematosus proliferate mononuclear cells in vitro. J Rheumatol 1999; 26: 294-301.
11. Banchereau, J, Briere, F, Caux, C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
12. Palucka, AK, Banchereau, J, Blanco, P, Pascual, V. The interplay of dendritic cell subsets in systemic lupus erythematosus. Immunol Cell Biol 2002; 80: 484-488.
13. O'Doherty, U, Peng, M, Gezelter, S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487-493.
14. Grouard, G, Rissoan, MC, Filgueira, L, Durand, I, Banchereau, J, Liu, YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997; 185: 1101-1111.
15. Shortman, K, Liu, YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2: 151-161.
16. Penna, G, Vulcano, M, Roncari, A, Facchetti, F, Sozzani, S, Adorini, L. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 2002; 169: 6673-6676.
17. Blom, B, Ho, S, Antonenko, S, Liu, YJ. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med 2000; 192: 1785-1796.
18. Siegal, FP, Kadowaki, N, Shodell, M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284: 1835-1837.
19. Ronnblom, L, Aim, GV. Systemic lupus erythematosus and the type I interferon system. Arthritis Res Ther 2003; 5: 68-75.
20. Olweus, J. BitMansour, A, Warnke, R, et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 1997; 94: 12551-12556.
21. Blanco, P, Palucka, AK, Gill, M, Pascual, V, Banchereau, J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
22. Vallin, H, Blomberg, S, Aim, GV, Cederblad, B, Ronnblom, L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol 1999; 115: 196-202.
23. Koller, M, Zwolfer, B, Steiner, G, Smolen, JS, Scheinecker, C. Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients. Int Immunol 2004; 16: 1595-1604.
24. Ronnblom, L, Aim, GV. The natural interferon-alpha producing cells in systemic lupus erythematosus. Hum Immunol 2002; 63: 1181-1193.
25. Fitzgerald-Bocarsly, P.. Natural interferon-alpha producing cells: the plasmacytoid dendritic cells. Biotechniques 2002; 22(Suppl. 16-20): 24-29.
26. Ronnblom, LE, Alm, GV, Oberg, KE. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990; 227: 207-210.
27. Robak, E, Smolewski, P, Wozniacka, A, Sysa-Jedrzejowska, A, Robak, T. Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus. Mediators Inflamm 2004; 13: 171-180.
28. Robak, E, Smolewski, P, Wozniacka, A, Sysa-Jedrzejowska, A, Stepien, H, Robak, T. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Eur Cytokine Netw 2004; 15: 222-230.
29. Gill, MA, Blanco, P, Arce, E, Pascual, V, Banchereau, J, Palucka, AK. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol 2002; 63: 1172-1180.
30. Scheinecker, C, Zwolfer, B, Koller, M, Manner, G, Smolen, JS. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum 2001; 44: 856-865.
31. Blomberg, S, Eloranta, ML, Magnusson, M, Alm, GV, Ronnblom, L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2524-2532.
32. Ding, D, Mehta, H, McCune, WJ, Kaplan, MJ. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 2006; 177: 5878-5889.
33. Decker, P, Kotter, I, Klein, R, Berner, B, Rammensee, HG. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006; 45: 1087-1095.
34. Sallusto, F, Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109 1118.
35. Siena, S, Di Nicola, M, Bregni, M, et al. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. Exp Hematol 1995; 23: 1463-1471.
36. Thurner, B, Roder, C, Dieckmann, D, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 1999; 223: 1-15.
37. Beckebaum, S, Zhang, X, Chen, X, et al. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 2004; 10: 7260-7269.
38. Dzionek, A, Fuchs, A, Schmidt, P, et al. BDCA-2, BDCA-3, and BDCA4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037-6046.
39. Dzionek, A, Inagaki, Y, Okawa, K, et al. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol 2002; 63: 1133-1148.
40. Osugi, Y, Vuckovic, S, Hart, DN. Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 2002; 100: 2858-2866.
41. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
42. Bombardier, C, Gladman, DD, Urowitz, MB, Caron, D, Chang, CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
43. Boor, PP, Ijzermans, JN, van der Molen, RG, et al. Immunomagnetic selection of functional dendritic cells from human lymph nodes. Immunol Lett 2005; 99: 162-168.
44. Bave, U, Magnusson, M, Eloranta, ML, Perers, A, Alm, GV, Ronnblom, L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol 2003; 171: 3296-3302.
45. Finkelman, FD, Lees, A, Birnbaum, R, Gause, WC, Morris, SC. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 1996; 157: 1406-1414.
46. Lanzavecchia, A, Sallusto, F. Lead and follow: the dance of the dendritic cell and T cell. Nat Immunol 2004; 5: 1201-1202.
47. Bave, U, Vallin, H, Alm, GV, Ronnblom, L. Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines. J Autoimmun 2001; 17: 71-80.
48. Vallin, H, Perers, A, Alm, GV, Ronnblom, L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 1999; 163: 6306-6313.
49. Means, TK, Latz, E, Hayashi, F, Murali, MR, Golenbock, DT, Luster, AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005; 115: 407-417.
50. Elkord, E, Williams, PE, Kynaston, H, Rowbottom, AW. Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 2005; 114: 204-212.
51. Zhou, LJ, Tedder, TF. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood 1995; 86: 3295-3301.
52. Zhou, L. TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996; 93: 2588-2592.
53. Lechmann, M, Zinser, E, Golka, A, Steinkasserer, A. Role of CD83 in the immunomodulation of dendritic cells. Int Arch Allergy Immunol 2002; 129: 113-118.
54. Fujimoto, Y, Tu, L, Miller, AS, et al. CD83 expression influences CD4+ T cell development in the thymus. Cell 2002; 108: 755-767.